Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Pilcher

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Focus (San Francisco, Calif.)|June 7, 2007
Lessons from primary HIV infectionFrederick Hecht, Christopher Pilcher
The Journal of Infectious Diseases|January 31, 2021
Microdrop Human Immunodeficiency Virus Sequencing for Incidence and Drug Resistance SurveillanceSung Yong Park, Gina Faraci, Gary Murphy, et al.
European Journal of Clinical Pharmacology|September 26, 2009
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitorsTodd Hulgan, John P Donahue, Laura Smeaton, et al.
AIDS and Behavior|January 4, 2014
Longitudinal characterization of depression and mood states beginning in primary HIV infectionJessica A Gold, Marie Grill, Julia Peterson, et al.
Antiviral Therapy|August 26, 2009
Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007Christopher B Hurt, Sandra I McCoy, Joann Kuruc, et al.
BMC Infectious Diseases|January 6, 2025
Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing: a pilot study in San FranciscoKelvin Moore, Noelle Le Tourneau, Jasmin Alvarez, et al.
Plos One|February 24, 2017
Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasmaKatherine E Schlusser, Christopher Pilcher, Esper G Kallas, et al.
AIDS (London, England)|March 19, 2019
RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic populationSusa Coffey, Peter Bacchetti, Darpun Sachdev, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2021
HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive PerformanceAugust A Longino, Robert Paul, Yixin Wang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
NF-κB dependent gene expression and plasma IL-1β, TNFα and GCSF drive transcriptomic diversity and CD4:CD8 ratio in people with HIV on ARTYingfan Wang, German G Gornalusse, David A Siegel, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Focus (San Francisco, Calif.)|June 7, 2007
Lessons from primary HIV infectionFrederick Hecht, Christopher Pilcher
The Journal of Infectious Diseases|January 31, 2021
Microdrop Human Immunodeficiency Virus Sequencing for Incidence and Drug Resistance SurveillanceSung Yong Park, Gina Faraci, Gary Murphy, et al.
European Journal of Clinical Pharmacology|September 26, 2009
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitorsTodd Hulgan, John P Donahue, Laura Smeaton, et al.
AIDS and Behavior|January 4, 2014
Longitudinal characterization of depression and mood states beginning in primary HIV infectionJessica A Gold, Marie Grill, Julia Peterson, et al.
Antiviral Therapy|August 26, 2009
Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007Christopher B Hurt, Sandra I McCoy, Joann Kuruc, et al.
BMC Infectious Diseases|January 6, 2025
Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing: a pilot study in San FranciscoKelvin Moore, Noelle Le Tourneau, Jasmin Alvarez, et al.
Plos One|February 24, 2017
Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasmaKatherine E Schlusser, Christopher Pilcher, Esper G Kallas, et al.
AIDS (London, England)|March 19, 2019
RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic populationSusa Coffey, Peter Bacchetti, Darpun Sachdev, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2021
HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive PerformanceAugust A Longino, Robert Paul, Yixin Wang, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
NF-κB dependent gene expression and plasma IL-1β, TNFα and GCSF drive transcriptomic diversity and CD4:CD8 ratio in people with HIV on ARTYingfan Wang, German G Gornalusse, David A Siegel, et al.
Pageof 2